ArticleViruses2024

Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.

Mark Underwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.